Skip to ContentSkip to Navigation
About usNews and EventsNews articles

Risk of kidney failure easier to predict

06 September 2013

A new method helps to better measure renal function. This means that a better estimate can be made of the risk of kidney failure and death due to cardiovascular disease. The new method is more reliable in people with very little muscle mass, such as the elderly and people with chronic diseases, and people who eat very little meat, such as vegetarians. The results are part of a large international research project headed by UMCG nephrologist Dr Ron Gansevoort and were published on 5 September in the New England Journal of Medicine.

Worldwide, about 10% of the population are confronted by reduced renal function that could lead to kidney failure and death due to cardiovascular disease. Gansevoort: ‘The earlier and more reliably the reduction in renal function can be estimated, the more targeted the treatment can be, thus, for example, avoiding the need for dialysis.’


Kidney patients are used to their renal function being determined by measuring the amount of creatinine in their blood. ‘Creatinine is a waste product of muscle cells and the body can only get rid of it if the kidneys excrete it in urine. The higher the creatinine levels in the blood, the poorer the kidneys are working’, explains Gansevoort. ‘We know that the creatinine method is not as reliable in people with very little muscle mass, like the elderly and people with chronic diseases. The new method measures the amount of a different substance in the blood, cystatin C. This is a waste product produced by every cell in the body and the amount of it in the blood is much more stable than for creatinine.’


The researchers have for the first time proved convincingly that the new method is a better predictor of kidney failure and death from cardiovascular disease. They combined the data from 11 population studies conducted in Europe, the US and Australia. The Dutch data concerned 8,000 people taking part in the Groningen PREVEND project. All of the studies conducted their measurements in the same way, so that comparisons between the predictive value of creatinine and crystatin C were possible.


‘Before you can introduce a new test as the standard, you have to know whether the substance is a good measurement of renal function and whether it is a good risk predictor. The latter is what we have convincingly demonstrated. However, the new test does cost more’, says Gansevoort. ‘Measuring cystatin C is currently advised as an additional test for people with a slightly disrupted renal function revealed by the creatinine measurement as a way to get a more reliable estimate of their prognosis. Our results may mean that the test becomes cheaper because it will be more in demand. Hopefully what will follow is implementation for all patients with renal function disorders.’

Last modified:15 September 2017 3.32 p.m.
printView this page in: Nederlands

More news

  • 24 May 2019

    Four UG researchers win Vidi grants

    The Netherlands Organisation for Scientific Research (NWO) has awarded an EUR 800,000 Vidi grant each to 86 experienced researchers. Four of these conduct their research at just one faculty at the University of Groningen (UG): the Faculty of Science...

  • 24 May 2019

    First edition of Top HR Leadership Programme successfully completed

    The University of Groningen Business School (UGBS) and the In the LEAD centre of expertise at the University of Groningen are looking back on a successful first edition of the Top HR Leadership programme. On 21 May, eight top HR professionals with different...

  • 22 May 2019

    The North of the Netherlands goes down under during Solar Challenge

    Students of Hanze University of Applied Sciences (UAS), University of Groningen and Noorderpoort will be competing in the Bridgestone World Solar Challenge in Australia for the first time, with their own uniquely built and designed solar car called...